Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Muzamil Ashraf Makhdoomi"'
Autor:
Nitesh Mishra, Shaifali Sharma, Ayushman Dobhal, Sanjeev Kumar, Himanshi Chawla, Ravinder Singh, Muzamil Ashraf Makhdoomi, Bimal Kumar Das, Rakesh Lodha, Sushil Kumar Kabra, Kalpana Luthra
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Some infants develop broadly neutralizing antibodies (bnAbs) to HIV in a shorter time frame than adults, but the reasons aren’t well understood. Here, the authors study a cohort of 51 HIV-1 clade C perinatally infected infants of Indian origin and
Externí odkaz:
https://doaj.org/article/0dc11c97dcc845ddb653c4c07121885e
Autor:
Rama Jayasundar, Somenath Ghatak, Muzamil Ashraf Makhdoomi, Kalpana Luthra, Aruna Singh, Thirumurthy Velpandian
Publikováno v:
Journal of Ayurveda and Integrative Medicine, Vol 10, Iss 2, Pp 94-101 (2019)
Background: Information from Ayurveda meeting the analytical challenges of modern technology is an area of immense relevance. Apart from the cerebral task of bringing together two different viewpoints, the question at the pragmatic level remains ‘w
Externí odkaz:
https://doaj.org/article/ed3d9034ce4f4e71a9e3757f67064a76
Autor:
Heena Aggarwal, Lubina Khan, Omkar Chaudhary, Sanjeev Kumar, Muzamil Ashraf Makhdoomi, Ravinder Singh, Kanika Sharma, Nitesh Mishra, Rakesh Lodha, Maddur Srinivas, Bimal Kumar Das, Sushil Kumar Kabra, Kalpana Luthra
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Several B cell defects are reported in HIV-1 infected individuals including variation in B cell subsets, polyclonal B cell activation and exhaustion, with broadly neutralizing antibodies elicited in less than 10–20% of the infected population. HIV-
Externí odkaz:
https://doaj.org/article/5d5524e1ce304f2eac4db3d3a8bd159c
Autor:
Sanjeev Kumar, Rajesh Kumar, Lubina Khan, Muzamil Ashraf Makhdoomi, Ramachandran Thiruvengadam, Madhav Mohata, Mudit Agarwal, Rakesh Lodha, Sushil Kumar Kabra, Subrata Sinha, Kalpana Luthra
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Progression of human immunodeficiency virus type-1 (HIV-1) infection in children is faster than adults. HIV-1 subtype C is responsible for more than 50% of the infections globally and more than 90% infections in India. To date, there is no effective
Externí odkaz:
https://doaj.org/article/d999423940294be1b6161fef6c6a47c5
Autor:
Himanshi Chawla, Nitesh Mishra, Kalpana Luthra, Ravinder Singh, Sushil K. Kabra, Shaifali Sharma, Rakesh Lodha, Ayushman Dobhal, Sanjeev Kumar, Bimal Kumar Das, Muzamil Ashraf Makhdoomi
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Nature Communications
Nature Communications
Broadly neutralizing antibodies (bnAbs) develop in a subset of HIV-1 infected individuals over 2–3 years of infection. Infected infants develop plasma bnAbs frequently and as early as 1-year post-infection suggesting factors governing bnAb inductio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d7848fa5c4f6df723718ca04a307e8
https://doaj.org/article/0dc11c97dcc845ddb653c4c07121885e
https://doaj.org/article/0dc11c97dcc845ddb653c4c07121885e
Autor:
Lakshya Veer Singh, Himanshu Verma, Kalpana Luthra, Purnima Kumar, Muzamil Ashraf Makhdoomi, Dhiraj Kumar, Vartika Sharma, Sovan Sarkar, Sarman Singh, Nabab Khan
Publikováno v:
Autophagy
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Opportunistic bacterial infections amongst HIV–infected individuals contribute significantly to HIV-associated mortality. The role of HIV-mediated modulation of innate mechanisms like autophagy in promoting opportunistic infections, however, remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90fb580506944c8723e1ed0ee14b3a14
http://europepmc.org/articles/PMC7610453
http://europepmc.org/articles/PMC7610453
Autor:
Lubina Khan, Muzamil Ashraf Makhdoomi, Sanjeev Kumar, Ambili Nair, Raiees Andrabi, Brenda E Clark, Kate Auyeung, Jayanta Bhattacharya, Madhu Vajpayee, Naveet Wig, Ralph Pantophlet, Kalpana Luthra
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125575 (2015)
Dissecting antibody specificities in the plasma of HIV-1 infected individuals that develop broadly neutralizing antibodies (bNAbs) is likely to provide useful information for refining target epitopes for vaccine design. Several studies have reported
Externí odkaz:
https://doaj.org/article/5920a5117ee44dd8b4015bc1a45a87bf
Autor:
Muzamil Ashraf Makhdoomi, Shaifali Sharma, Kalpana Luthra, Bimal Kumar Das, Himanshi Chawla, Sushil K. Kabra, Nitesh Mishra, Ayushman Dobhal, Ravinder Singh, Sanjeev Kumar, Rakesh Lodha
Due to the extensive antigenic diversity of human immunodeficiency virus-1 (HIV-1), broadly neutralizing antibodies (bnAbs) develop in a subset of infected individuals over 2-3 years of infection. Interestingly, infected infants have been shown to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba4e63b126910eb6e6b229e822fe368a
https://doi.org/10.1101/837039
https://doi.org/10.1101/837039
Autor:
Sushil K. Kabra, Ayushman Dobhal, Deepshikha Kumar, Himanshi Chawla, Sanjeev Kumar, Shaifali Sharma, Uma Kanga, Muzamil Ashraf Makhdoomi, Rakesh Lodha, Ravinder Singh, Bimal Kumar Das, Kalpana Luthra, Nitesh Mishra
Publikováno v:
Journal of Virology. 93
Broad and potent neutralizing antibodies (bnAbs) with multiple epitope specificities evolve in HIV-1-infected children. Herein, we studied two antiretroviral-naive chronically HIV-1 clade C-infected monozygotic pediatric twins, AIIMS_329 and AIIMS_33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0736ad8e0b96aee3a46528a8acee87
https://doi.org/10.1128/jvi.00654-19
https://doi.org/10.1128/jvi.00654-19
Autor:
Himanshi Chawla, Sanjeev Kumar, Harekrushna Panda, Haaris Ahsan Safdari, Nitesh Mishra, Sushil K. Kabra, Anmol Chandele, Muzamil Ashraf Makhdoomi, Somnath Dutta, Rakesh Lodha, Kalpana Luthra, Elluri Seetharami Reddy, Heena Aggarwal
Publikováno v:
Journal of virology. 93(4)
Broadly neutralizing antibodies (bNAbs) have demonstrated protective effects against HIV-1 in primate studies and recent human clinical trials. Elite neutralizers are potential candidates for isolation of HIV-1 bNAbs. The coexistence of bNAbs such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0166174c0d2df0b8b1019c5ab1db2019
https://pubmed.ncbi.nlm.nih.gov/30429339
https://pubmed.ncbi.nlm.nih.gov/30429339